Selective Serotonin Reuptake Inhibitors (SSRIs), Childhood and Adolescent Depression, and Suicidality Following the FDA's 2004 Black Box Warning: A Systematized Literature Review

Harlin Kaur, Aksha Memon · 2025

Read Selective Serotonin Reuptake Inhibitors (SSRIs), Childhood and Adolescent Depression, and Suicidality Following the FDA's 2004 Black Box Warning: A Systematized Literature Review by Harlin Kaur, Aksha Memon (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12854806.txt.

Description

Harlin Kaur and Aksha Memon wrote this 2025 review of a long debate in child mental health. The topic is a class of antidepressant drugs called SSRIs, used to treat depression in children and teens. In 2004 the US drug agency put its strongest warning on these drugs over fears they raise suicide risk.

The authors searched the medical literature and chose eight studies to weigh in depth. Most found a small rise in suicidal thoughts early in treatment with these drugs. Trials were mixed on whether the drugs alone caused the rise. Care that paired a drug with talk therapy tended to do best. The review urges close watch in the first weeks of care.

Catalog record

CREATORHarlin Kaur, Aksha Memon
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE27 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12854806

Browse the full library · About the Tower of Babel